Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Revuforj® (revumenib)
-
Security Federal Announces Cash Dividend
-
Gymboree Marks Historic Grand Opening at Garden State Plaza
-
Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology
-
CCC, StandardAero sign contract worth over $80M to repair U.S. Navy surface fleet engines
-
Glacier Bancorp, Inc. Declares Quarterly Dividend
-
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference
-
Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
-
Trump Media CEO Devin Nunes Congratulates Linda McMahon on Cabinet Appointment
-
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
-
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
-
Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
-
YXT.com Group Holding Limited to Announce Financial Results for the First Nine Months of 2024 on November 26, 2024
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Rakovina Therapeutics Announces Upcoming Poster Presentation at the 29th Annual Society for Neuro-Oncology Meeting in Houston, Texas
-
Mitsubishi HC Capital Canada Launches New, Best in Class Vendor Portal
-
NVIDIA Announces Financial Results for Third Quarter Fiscal 2025
-
Mitsubishi HC Capital America Enhances Best in Class Vendor Portal
-
Black Oak Casino Resort Chooses QCI Chatalytics™ to Enhance Casino Operations with Integrated AI Solutions
-
TopBuild to Acquire Metro Supply Company
-
Applied Optoelectronics Filed Patent Infringement Lawsuit Against Eoptolink Technology USA Inc.
-
Matthews International Increases Quarterly Dividend
-
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for Im
-
Dynagas LNG Partners LP Announces Date for the Release of the Third Quarter 2024 Results
-
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
-
Lexicon Appoints Ivan H. Cheung to Board of Directors
-
Allbirds to Participate in Upcoming Investor Conference
-
Jewett-Cameron Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results
-
Financial Institutions, Inc. Announces Quarterly Cash Dividend
-
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
-
Pyxis Tankers Announces Date for the Release of the Third Quarter 2024 Results and Related Conference Call & Webcast
-
Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024
-
Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Color Star Technology Received Nasdaq Notification Letter Regarding Bid Price Deficiency
-
Euroseas Ltd. Reports Results for the Nine-Month Period and Quarter Ended September 30, 2024, Declares Quarterly Dividend and Announces Order for the Construction of Two Fuel-Efficient 4,300 TEU Conta
-
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
-
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
-
Color Star Technology Received Nasdaq Notification Letter Regarding Bid Price Deficiency
-
Verrica Announces Proposed Public Offering
-
Navigator Gas Announces Two Additional 48,500 Cubic Meter Capacity Liquefied Ethylene Gas Carrier Newbuilds
-
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
Pyxis Tankers Announces Date for the Release of the Third Quarter 2024 Results and Related Conference Call & Webcast
-
Latin American and Caribbean Companies Commit to Accelerating SDG Progress
-
Crown Highlights Trump Administration Potential Impact on Its Water Solutions Division
-
Five Below, Inc. Announces Third Quarter Fiscal 2024 Earnings Release and Conference Call Date
-
Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
-
SquareX Brings Industry’s First Browser Detection Response Solution to AISA Melbourne CyberCon 2024
-
Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024
-
Combined General Meeting of December 11, 2024 - Availability of the preparatory documents

